Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-16-567707
Filing Date
2016-04-29
Accepted
2016-04-29 13:01:11
Documents
8
Period of Report
2016-06-23
Effectiveness Date
2016-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A d306848ddef14a.htm DEF 14A 881489
2 GRAPHIC g306848g09q82.jpg GRAPHIC 68382
3 GRAPHIC g306848g36i66.jpg GRAPHIC 6692
4 GRAPHIC g306848g66q90.jpg GRAPHIC 85484
5 GRAPHIC g306848g80g88.jpg GRAPHIC 94795
6 GRAPHIC g306848pcpg001a.jpg GRAPHIC 3712
7 GRAPHIC g306848pcpg001b.jpg GRAPHIC 2934
8 GRAPHIC g306848pcpg002.jpg GRAPHIC 2948
  Complete submission text file 0001193125-16-567707.txt   1248626
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

EIN.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-24006 | Film No.: 161604611
SIC: 2834 Pharmaceutical Preparations